Navigation Links
Lilly Announces Continued Commitment to Transparency with Faculty Registry
Date:7/31/2009

INDIANAPOLIS, July 31 /PRNewswire-FirstCall/ -- Today Eli Lilly and Company (NYSE: LLY) launched an online registry detailing recent payments it has made to physicians and other health care professionals - a report known as its "faculty registry." The data are for the first quarter of 2009; Lilly will update the registry quarterly going forward.

Lilly faculty are physicians and other health care professionals contracted to provide specific services on behalf of Lilly and the Lilly alliance partnerships. Faculty appearing in the registry either advised Lilly or conducted medical lectures designed for health care professionals and patient education. The site discloses each professional's name, location, description of the services provided and the compensation paid, among other details.

"This registry is consistent with Lilly's efforts to increase transparency," said Jack Harris, M.D., Lilly's vice president of its U.S. medical division. "We see greater transparency as integral to rebuilding trust in our industry."

Nearly 3,400 physicians and other health care professionals are in the dataset. The average payment per service provided is just over $1,000, with health care professionals conducting six activities on average. The data are available at www.lillyfacultyregistry.com.

"Our contracted faculty are key resources in our efforts to improve individual patient outcomes," Harris said. "They advise us on how to bring the best new cures and treatments to market, and give lectures to their peers on Lilly products and disease-state information to help keep them current on the ever-changing field of medicine. And many of our faculty educate patients, at the request of their treating physician, on how to use the Lilly medicine prescribed to them."

Lilly's faculty registry is part of its commitment to enhancing transparency. In 2004, Lilly became the first company to voluntarily make public its clinical trials and its clinical trials data at www.lillytrials.com. In 2007, Lilly added another first by publicly reporting all of its educational grants and charitable contributions and, each quarter, posting the data online at www.lillygrantoffice.com.

Lilly announced last September it would begin to voluntarily disclose physician payments starting in the second half of 2009. In February 2009, Lilly entered into a Corporate Integrity Agreement with the Office of the Inspector General of the U.S. Department of Health and Human Services and was required to disclose the information.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO)

C-LLY


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lilly to Unveil More Than 30 Studies at Premier Lung Cancer Meeting
2. Lilly Receives Award From National Medical Association
3. FDA Approves Expanded Use of Lillys FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis
4. Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
5. Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)
6. Lilly Celebrates Its 35th Year as a Supporter of the Indiana Black Expo
7. Lilly Sets Date and Conference Call for Second-Quarter 2009 Financial Results Announcement
8. Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
9. Lilly Declares Third-Quarter Dividend
10. New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimers Disease Market
11. Eli Lilly and Company Announces New Drug Discovery Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Oct. 12, 2017 AVACEN Medical , Inc. ... with their  2017 New Product Innovation Award for Its ... primary and secondary medical device market research by Frost & ... first-to-market OTC, drug-free pain relief product, the AVACEN 100, offers ... treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
Breaking Medicine Technology: